##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H129-301222-ROCHE_S77_R
1	13260220	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=1;Span=47076;GeneNames=PRAMEF5,PRAMEF8,PRAMEF33;GeneIDs=343068,391002,645382;Aliases=PRAMEF23,PRAMEF5L;Genes=3;TranscriptNameClinicallyRelevant=NM_001013407.5,NM_001012276.3,NM_001291381.1;OverlappingExonsClinicallyRelevant=3-4,All,1-3;HGVSg=NC_000001.11:g.13260220_13307295dup;HGVScClinicallyRelevant=NM_001013407.5:c.288-2_1431dup,.,NM_001291381.1:c.1_866+79dup;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(1)p36.21;SequenceOntologyClinicallyRelevant=transcript_ablation,.,transcript_ablation;RegionClinicallyRelevant=exon,.,exon;Region=1:13184700-13392942,1:13260717-13315806;Span2=208243,55090;OverlapType=Within Region,Partial Overlap;Name=gssvG346,gssvG360;Frequency=0.0012,0.3134;Type2=Gain,Gain;Region2=1:13184701-13364099;Span3=179399;OverlapType2=Within Region;Type3=Duplication;Frequency2=0.00444444;DeletionFrequency=0;DuplicationFrequency=0.00444444;END=13307295	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:182.552:1.57995:1.58668:9.86314878038266e-05:PRAMEF5,PRAMEF8,PRAMEF33::PRAMEF5:NM_001013407.5:VUS:2L0ThiscnvpartiallyoverlapsthePRAMEF5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	25284564	.	N	<DEL>	.	.	Type=Loss;Targets=10;Samples2=9;Span=44581;GeneNames=RHD,RSRP1;GeneIDs=57035,6007;Aliases=C1orf63,NPD014;Genes=2;TranscriptNameClinicallyRelevant=NM_016124.6,NM_001321772.2;OverlappingExonsClinicallyRelevant=2-10,.;HGVSg=NC_000001.11:g.25284564_25329144del;HGVScClinicallyRelevant=NM_016124.6:c.149-9_1254del,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(1)p36.11;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;Region=1:25247031-25367695,1:25258853-25313871,1:25266637-25338175,1:25301582-25338308;Span2=120665,55019,71539,36727;OverlapType=Within Region,Partial Overlap,Within Region,Partial Overlap;Name=gssvL1588,gssvL1591,gssvL1590,gssvL1592;Frequency=0.1525,0.014,0.0084,0.0149;Type2=Loss,Loss,Loss,Loss;Region2=1:25266921-25336019;Span3=69099;OverlapType2=Within Region;Type3=Deletion;Frequency2=0.436047;DeletionFrequency=0.436047;DuplicationFrequency=0;END=25329144	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-2.49598:0:1.36195466932617e-13:RHD,RSRP1::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:0
1	93154660	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=5577;GeneNames=TMED5;GeneIDs=50999;Aliases=CGI-100,p24g2,p28;Genes=1;TranscriptNameClinicallyRelevant=NM_016040.5;OverlappingExonsClinicallyRelevant=2-4;HGVSg=NC_000001.11:g.93154660_93160236dup;HGVScClinicallyRelevant=NM_016040.5:c.190-10_690dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p22.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=93160236	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:102.709:2.7065:1.28909:4.25140040130687e-07:TMED5::TMED5:NM_016040.5:VUS:2L0ThiscnvpartiallyoverlapstheTMED5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	120441219	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=6;Span=14304;GeneNames=NBPF8;GeneIDs=728841;Aliases=NBPF8P;Genes=1;TranscriptNameClinicallyRelevant=NM_001037501.5;OverlappingExonsClinicallyRelevant=8-14;HGVSg=NC_000001.11:g.120441219_120455522dup;HGVScClinicallyRelevant=NM_001037501.5:c.567-59_1637+62dup;HGVSpClinicallyRelevant=NP_001032590.2:p.E190_R546dup;ISCNCytobandNotation=dup(1)p11.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=120455522	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:178.762:1.75865:1.44495:3.4461537903698e-06:NBPF8::NBPF8:NM_001037501.5:VUS:2L0ThiscnvpartiallyoverlapstheNBPF8genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	207563854	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=4;Span=4277;GeneNames=CR1;GeneIDs=1378;Aliases=C3BR,C4BR,CD35,KN;Genes=1;TranscriptNameClinicallyRelevant=NM_000651.6;OverlappingExonsClinicallyRelevant=22-25;HGVSg=NC_000001.11:g.207563854_207568130dup;HGVScClinicallyRelevant=NM_000651.6:c.3587-10_4171+88dup;HGVSpClinicallyRelevant=NP_000642.3:p.V1196_L1390dup;ISCNCytobandNotation=dup(1)q32.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;Region2=1:207558604-207567633;Span3=9030;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=207568130	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:227.841:1.72886:1.42415:0.00032083577420811:CR1::CR1:NM_000651.6:Benign:2L0ThiscnvpartiallyoverlapstheCR1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
2	90114810	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=10;Span=45347;Region=2:90074886-90282543;Span2=207658;OverlapType=Within Region;Name=gssvG20578;Frequency=0.0014;Type2=Gain;Region2=2:90079896-90262422,2:90121315-90201621;Span3=182527,80307;OverlapType2=Within Region,Partial Overlap;Type3=Duplication,Duplication;Frequency2=0.00185842,0.000168947;DeletionFrequency=0,0;DuplicationFrequency=0.00185842,0.000168947;END=90160156	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:136.311:3.06137:2.8847:1.5101710122472e-10:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,3A0Thiscnvoverlaps0proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
2	95895369	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=7;Span=242;GeneNames=ANKRD36C;GeneIDs=400986;Genes=1;TranscriptNameClinicallyRelevant=NM_001393982.1;OverlappingExonsClinicallyRelevant=61-62;HGVSg=NC_000002.12:g.95895369_95895610dup;HGVScClinicallyRelevant=NM_001393982.1:c.3572-20_3673+30dup;HGVSpClinicallyRelevant=NP_001380911.1:p.R1194_S1227dup;ISCNCytobandNotation=dup(2)q11.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=95895610	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:125.517:3.3864:1.91569:7.78958069027283e-06:ANKRD36C::ANKRD36C:NM_001393982.1:Benign:2L0ThiscnvpartiallyoverlapstheANKRD36Cgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
2	97209661	.	N	<DUP>	.	.	Type=Gain;Targets=13;Samples2=1;Span=36411;GeneNames=ANKRD36;GeneIDs=375248;Aliases=UNQ2430;Genes=1;TranscriptNameClinicallyRelevant=NM_001354587.1;OverlappingExonsClinicallyRelevant=55-71;HGVSg=NC_000002.12:g.97209661_97246071dup;HGVScClinicallyRelevant=NM_001354587.1:c.3266-20_5406dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(2)q11.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region=2:97136585-97254892,2:97233824-97251937;Span2=118308,18114;OverlapType=Within Region,Partial Overlap;Name=gssvG20870,gssvG20884;Frequency=0.0016,0.0597;Type2=Gain,Gain;END=97246071	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:159.282:1.57841:1.42366:1.06270949099759e-07:ANKRD36::ANKRD36:NM_001354587.1:VUS:2L0ThiscnvpartiallyoverlapstheANKRD36genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	75665513	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=1;Span=117868;GeneNames=FRG2C,LINC00960,MIR4273,ZNF717;GeneIDs=100288801,401074,100131827,100422955;Genes=4;TranscriptNameClinicallyRelevant=NM_001124759.5,NR_040005.1,NR_036235.1,NM_001290208.3;OverlappingExonsClinicallyRelevant=4,All,All,2-5;HGVSg=NC_000003.12:g.75665513_75783380dup;HGVScClinicallyRelevant=NM_001124759.5:c.335-14_849dup,.,.,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(3)p12.3;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.,.;RegionClinicallyRelevant=exon,.,.,.;Region=3:75347667-75869718,3:75577678-75716825,3:75646366-75760107,3:75690200-75759935,3:75716432-75744436;Span2=522052,139148,113742,69736,28005;OverlapType=Within Region,Partial Overlap,Partial Overlap,Contains Region,Contains Region;Name=gssvG25624,gssvG25628,gssvG25630,gssvG25635,gssvG25641;Frequency=0.0014,0.275,0.0008,0.0016,0.1091;Type2=Gain,Gain,Gain,Gain,Gain;Region2=3:75518090-75768048,3:75676314-75752521;Span3=249959,76208;OverlapType2=Partial Overlap,Contains Region;Type3=Duplication,Duplication;Frequency2=0.025,0.15;DeletionFrequency=0,0;DuplicationFrequency=0.025,0.15;END=75783380	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:233.079:2.15268:1.27527:1.25920206776049e-08:FRG2C,LINC00960,MIR4273,ZNF717::FRG2C:NM_001124759.5:VUS:2L0ThiscnvpartiallyoverlapstheFRG2Cgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
5	32107959	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=5;Span=35916;GeneNames=GOLPH3,PDZD2;GeneIDs=23037,64083;Aliases=AIPC,PAPIN,PDZK3;Genes=2;TranscriptNameClinicallyRelevant=NM_022130.4,NM_178140.4;OverlappingExonsClinicallyRelevant=2-4,25;HGVSg=NC_000005.10:g.32107959_32143874dup;HGVScClinicallyRelevant=NM_022130.4:c.232_897dup,NM_178140.4:c.8354-10_8520dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(5)p13.3;SequenceOntologyClinicallyRelevant=3_prime_UTR_variant,transcript_ablation;RegionClinicallyRelevant=UTR3,exon;Region=5:32081305-32202633,5:32105362-32137743,5:32106978-32158337;Span2=121329,32382,51360;OverlapType=Within Region,Partial Overlap,Within Region;Name=gssvG29655,gssvG29661,gssvG29657;Frequency=0.0246,0.0055,0.0042;Type2=Gain,Gain,Gain;Region2=5:32105141-32171908,5:32106979-32155849,5:32107831-32135475;Span3=66768,48871,27645;OverlapType2=Within Region,Within Region,Partial Overlap;Type3=Duplication,Duplication,Duplication;Frequency2=0.0260355,0.0368305,0.00118343;DeletionFrequency=0,0,0;DuplicationFrequency=0.0260355,0.0368305,0.00118343;END=32143874	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:259.329:4.10493:1.64383:1.50648375942282e-14:GOLPH3,PDZD2::GOLPH3:NM_022130.4:Benign:2L0ThiscnvpartiallyoverlapstheGOLPH3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
5	140842883	.	N	<DEL>	.	.	Type=Loss;Targets=6;Samples2=15;Span=15739;GeneNames=PCDHA1,PCDHA2,PCDHA3,PCDHA4,PCDHA5,PCDHA6,PCDHA7,PCDHA8,PCDHA9,PCDHA10;GeneIDs=56147,56146,56145,56144,56143,56142,56141,56140,9752,56139;Aliases=PCDH-ALPHA1;Genes=10;TranscriptNameClinicallyRelevant=NM_018900.4,NM_018905.3,NM_018906.3,NM_018907.4,NM_018908.3,NM_018909.4,NM_018910.3,NM_018911.3,NM_031857.2,NM_018901.4;OverlappingExonsClinicallyRelevant=.,.,.,.,.,.,.,1,1,1;HGVSg=NC_000005.10:g.140842883_140858621del;HGVScClinicallyRelevant=NM_018900.4:c.2394+54199_2394+69937del,NM_018905.3:c.2388+45531_2388+61269del,NM_018906.3:c.2394+39292_2394+55030del,NM_018907.4:c.2385+33311_2385+49049del,NM_018908.3:c.2352+18756_2352+34494del,NM_018909.4:c.2394+12398_2394+28136del,NM_018910.3:c.2355+6145_2355+21883del,NM_018911.3:c.1562_2394+14906del,NM_031857.2:c.1_2394+7732del,NM_018901.4:c.1_2388+185del;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,NP_061734.1:p.?,.,.;ISCNCytobandNotation=del(5)q31.3;SequenceOntologyClinicallyRelevant=intron_variant,intron_variant,intron_variant,intron_variant,intron_variant,intron_variant,intron_variant,splice_donor_variant,transcript_ablation,transcript_ablation;RegionClinicallyRelevant=intron,intron,intron,intron,intron,intron,intron,exon,exon,exon;Region=5:140835344-140852254,5:140839141-140874533,5:140841349-140862645,5:140843360-140852254,5:140847633-140857963;Span2=16911,35393,21297,8895,10331;OverlapType=Partial Overlap,Within Region,Within Region,Contains Region,Contains Region;Name=gssvL102656,gssvL102653,gssvL102655,gssvL102661,gssvL102660;Frequency=0.0106,0.0187,0.0711,0.0527,0.0505;Type2=Loss,Loss,Loss,Loss,Loss;Region2=5:140842553-140859346,5:140842565-140859300,5:140843567-140848915,5:140844252-140852254,5:140848187-140857112,5:140850767-140855647;Span3=16794,16736,5349,8003,8926,4881;OverlapType2=Within Region,Within Region,Contains Region,Contains Region,Contains Region,Contains Region;Type3=Deletion,Deletion,Deletion,Deletion,Deletion,Deletion;Frequency2=0.0766385,0.144444,0.0819239,0.00743369,0.00118343,0.0803383;DeletionFrequency=0.0766385,0.144444,0.0819239,0.00743369,0.00118343,0.0803383;DuplicationFrequency=0,0,0,0,0,0;END=140858621	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:109.103:-2.3138:0.589633:1.11898413560043e-07:PCDHA1,PCDHA2,PCDHA3,PCDHA4,PCDHA5,PCDHA6,PCDHA7,PCDHA8,PCDHA9,PCDHA10::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps10proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
5	177731488	.	N	<DUP>	.	.	Type=Gain;Targets=11;Samples2=8;Span=17243;GeneNames=FAM153A;GeneIDs=285596;Aliases=NY-REN-7;Genes=1;TranscriptNameClinicallyRelevant=NM_001394339.1;OverlappingExonsClinicallyRelevant=3-16;HGVSg=NC_000005.10:g.177731488_177748730dup;HGVScClinicallyRelevant=NM_001394339.1:c.176-31_862+81dup;HGVSpClinicallyRelevant=NP_001381268.1:p.K287_S288ins229;ISCNCytobandNotation=dup(5)q35.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=177748730	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:92.0818:1.29454:1.61597:6.3471917144814e-05:FAM153A::FAM153A:NM_001394339.1:Benign:2L0ThiscnvpartiallyoverlapstheFAM153Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
6	31994489	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=1;Span=32624;GeneNames=C4A,C4B,CYP21A1P,TNXA;GeneIDs=720,1590,7146,721;Aliases=C4,C4A2,C4A3,C4A4,C4A6,C4AD,C4S,CO4,CPAMD2,RG;Genes=4;TranscriptNameClinicallyRelevant=NM_007293.3,NM_001002029.4,NR_040090.1,NR_001284.2;OverlappingExonsClinicallyRelevant=21-41,1-20,All,All;HGVSg=NC_000006.12:g.31994489_32027112dup;HGVScClinicallyRelevant=NM_007293.3:c.2593-9_5235dup,NM_001002029.4:c.1_2582dup,.,.;HGVSpClinicallyRelevant=.,NP_001002029.3:p.N862*,.,.;ISCNCytobandNotation=dup(6)p21.33;SequenceOntologyClinicallyRelevant=transcript_ablation,frameshift_variant,.,.;RegionClinicallyRelevant=exon,exon,.,.;Region=6:31980357-32057861,6:31991099-32017745,6:32006063-32035417;Span2=77505,26647,29355;OverlapType=Within Region,Partial Overlap,Partial Overlap;Name=gssvG32064,gssvG32065,gssvG32067;Frequency=0.2375,0.0071,0.1212;Type2=Gain,Gain,Gain;Region2=6:31991100-32017745,6:31991161-32017701;Span3=26646,26541;OverlapType2=Partial Overlap,Partial Overlap;Type3=Duplication,Duplication;Frequency2=0.92,0.175;DeletionFrequency=0,0;DuplicationFrequency=0.92,0.175;END=32027112	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:217.759:1.56317:1.41487:3.77055503087015e-05:C4A,C4B,CYP21A1P,TNXA::C4A:NM_007293.3:Benign:2L0ThiscnvpartiallyoverlapstheC4Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
6	32517718	.	N	<DUP>	.	.	Type=Gain;Targets=19;Samples2=7;Span=142543;GeneNames=HLA-DQA1,HLA-DQB1,HLA-DQB1-AS1,HLA-DRB1,HLA-DRB5,HLA-DRB6;GeneIDs=3127,3128,3123,3117,3119,106480429;Aliases=HLA-DRB5*;Genes=6;TranscriptNameClinicallyRelevant=NM_002122.5,NM_002123.5,NR_133907.1,NM_002124.4,NM_002125.4,NR_001298.1;OverlappingExonsClinicallyRelevant=All,5,1,All,All,All;HGVSg=NC_000006.12:g.32517718_32660260dup;HGVScClinicallyRelevant=.,NM_002123.5:c.773-11_786dup,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.;ISCNCytobandNotation=dup(6)p21.32;SequenceOntologyClinicallyRelevant=.,transcript_ablation,.,.,.,.;RegionClinicallyRelevant=.,exon,.,.,.,.;Region=6:32440750-32578591,6:32444130-32812059,6:32462117-32664980,6:32530264-32584162,6:32533367-32616832,6:32536048-32673970,6:32552780-32584167,6:32581949-32629439;Span2=137842,367930,202864,53899,83466,137923,31388,47491;OverlapType=Partial Overlap,Within Region,Within Region,Contains Region,Contains Region,Partial Overlap,Contains Region,Contains Region;Name=gssvG32084,gssvG32080,gssvG32082,gssvG32090,gssvG32088,gssvG32083,gssvG32096,gssvG32092;Frequency=0.0232,0.0058,0.0064,0.004,0.0039,0.0223,0.0986,0.1219;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=6:32444131-32812059,6:32457996-32793120,6:32554404-32583873,6:32586777-32625050;Span3=367929,335125,29470,38274;OverlapType2=Within Region,Within Region,Contains Region,Contains Region;Type3=Duplication,Duplication,Duplication,Duplication;Frequency2=0.275556,0.475,0.125,0.125;DeletionFrequency=0,0,0,0;DuplicationFrequency=0.275556,0.475,0.125,0.125;END=32660260	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:151.326:1.45123:1.65135:3.39630300979776e-09:HLA-DQA1,HLA-DQB1,HLA-DQB1-AS1,HLA-DRB1,HLA-DRB5,HLA-DRB6::HLA-DQB1:NM_002123.5:Benign:2L0ThiscnvpartiallyoverlapstheHLA-DQB1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps4proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
6	108323816	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=32999;GeneNames=AFG1L;GeneIDs=246269;Aliases=AFG1,LACE1,c222389;Genes=1;TranscriptNameClinicallyRelevant=NM_145315.5;OverlappingExonsClinicallyRelevant=2-5;HGVSg=NC_000006.12:g.108323816_108356814dup;HGVScClinicallyRelevant=NM_145315.5:c.140-9_642dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(6)q21;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region2=6:108346889-108356831;Span3=9943;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=108356814	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:179.698:3.28046:1.28576:6.66206626964892e-12:AFG1L::AFG1L:NM_145315.5:VUS:2L0ThiscnvpartiallyoverlapstheAFG1Lgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
7	142095556	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=1;Span=2110;GeneNames=MGAM;GeneIDs=8972;Aliases=MG;Genes=1;TranscriptNameClinicallyRelevant=NM_004668.3;OverlappingExonsClinicallyRelevant=41-43;HGVSg=NC_000007.14:g.142095556_142097665del;HGVScClinicallyRelevant=NM_004668.3:c.4771-9_5061+16del;HGVSpClinicallyRelevant=NP_004659.2:p.R1591_T1687del;ISCNCytobandNotation=del(7)q34;SequenceOntologyClinicallyRelevant=inframe_deletion;RegionClinicallyRelevant=exon;END=142097665	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:70.7838:-3.25304:0.620615:1.33834825352835e-07:MGAM::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
9	67867271	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=3;Span=33884;GeneNames=ANKRD20A1;GeneIDs=84210;Aliases=ANKRD20A;Genes=1;TranscriptNameClinicallyRelevant=NM_032250.5;OverlappingExonsClinicallyRelevant=4-15;HGVSg=NC_000009.12:g.67867271_67901154dup;HGVScClinicallyRelevant=NM_032250.5:c.493-6_2159dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(9)q21.11;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=67901154	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:102.681:1.62173:1.63674:1.89141806418345e-05:ANKRD20A1::ANKRD20A1:NM_032250.5:VUS:2L0ThiscnvpartiallyoverlapstheANKRD20A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	111744633	.	N	<DUP>	.	.	Type=Gain;Targets=30;Samples2=1;Span=126559;GeneNames=ACAD10,ALDH2,MAPKAPK5,MAPKAPK5-AS1,MIR6761;GeneIDs=80724,217,102465456,51275,8550;Genes=5;TranscriptNameClinicallyRelevant=NM_025247.6,NM_000690.4,NM_003668.4,NR_015404.2,NR_106819.1;OverlappingExonsClinicallyRelevant=13-21,All,1-7,All,All;HGVSg=NC_000012.12:g.111744633_111871191dup;HGVScClinicallyRelevant=NM_025247.6:c.1715-10_3180dup,.,NM_003668.4:c.1_579+11dup,.,.;HGVSpClinicallyRelevant=.,.,.,.,.;ISCNCytobandNotation=dup(12)q24.12;SequenceOntologyClinicallyRelevant=transcript_ablation,.,transcript_ablation,.,.;RegionClinicallyRelevant=exon,.,exon,.,.;Region=12:111732560-111884067;Span2=151508;OverlapType=Within Region;Name=gssvG9140;Frequency=0.0028;Type2=Gain;Region2=12:111743268-111883947,12:111839773-111876910;Span3=140680,37138;OverlapType2=Within Region,Partial Overlap;Type3=Duplication,Duplication;Frequency2=0.00135158,0.000168947;DeletionFrequency=0,0;DuplicationFrequency=0.00135158,0.000168947;END=111871191	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:198.849:3.66735:1.31303:5.09350945229007e-79:ACAD10,ALDH2,MAPKAPK5,MAPKAPK5-AS1,MIR6761::ACAD10:NM_025247.6:VUS:2L0ThiscnvpartiallyoverlapstheACAD10genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
14	18967477	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=2;Span=29682;GeneNames=LOC100508046,POTEM;GeneIDs=641455,100508046;Aliases=ACT,P704P,POTE14beta;Genes=2;TranscriptNameClinicallyRelevant=NR_110505.1,NM_001145442.1;OverlappingExonsClinicallyRelevant=All,1-10;HGVSg=NC_000014.9:g.18967477_18997158dup;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(14)q11.2;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;Region=14:18967434-19004769;Span2=37336;OverlapType=Within Region;Name=gssvG10848;Frequency=1;Type2=Gain;END=18997158	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:200.367:2.24621:2.08696:2.844837429469e-09:LOC100508046,POTEM::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
14	106088100	.	N	<DEL>	.	.	Type=Loss;Targets=23;Samples2=1;Span=272184;GeneNames=LINC00226;GeneIDs=338004;Aliases=C14orf97,NCRNA00226;Genes=1;TranscriptNameClinicallyRelevant=NR_033375.2;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000014.9:g.106088100_106360283del;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(14)q32.33;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;Region=14:105602427-106819100,14:105728128-106433148,14:105862975-106212858,14:106001887-106468393,14:106034039-106222837,14:106063917-106725450,14:106117952-106459700,14:106140812-106331007,14:106209485-106324499,14:106210472-106276715,14:106225666-106389549,14:106257130-106327698,14:106260747-106477939;Span2=1216674,705021,349884,466507,188799,661534,341749,190196,115015,66244,163884,70569,217193;OverlapType=Within Region,Within Region,Partial Overlap,Within Region,Partial Overlap,Within Region,Partial Overlap,Contains Region,Contains Region,Contains Region,Partial Overlap,Contains Region,Partial Overlap;Name=gssvL37119,gssvL37121,gssvL37131,gssvL37124,gssvL37141,gssvL37120,gssvL37129,gssvL37136,gssvL37156,gssvL37179,gssvL37145,gssvL37187,gssvL37134;Frequency=0.0064,0.0349,0.0019,0.0169,0.0034,0.0017,0.005,0.0019,0.0007,0.0021,0.0027,0.0143,0.001;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;Region2=14:106154302-106294191,14:106183779-106271404;Span3=139890,87626;OverlapType2=Contains Region,Contains Region;Type3=Deletion,Deletion;Frequency2=0.000844737,0.025;DeletionFrequency=0.000844737,0.025;DuplicationFrequency=0,0;END=106360283	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:130.548:-1.36817:0.752942:7.68716835992279e-10:LINC00226::LINC00226:NR_033375.2:Benign:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-37477inClinGenDosageSensitivity.,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:1
15	30407266	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=2;Span=1036;GeneNames=GOLGA8R;GeneIDs=101059918;Genes=1;TranscriptNameClinicallyRelevant=NM_001282484.1;OverlappingExonsClinicallyRelevant=10-12;HGVSg=NC_000015.10:g.30407266_30408301dup;HGVScClinicallyRelevant=NM_001282484.1:c.679-6_1128+9dup;HGVSpClinicallyRelevant=NP_001269413.1:p.L227_L376dup;ISCNCytobandNotation=dup(15)q13.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=30408301	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:147.967:2.40314:1.57975:0.000104881078740745:GOLGA8R::GOLGA8R:NM_001282484.1:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46687inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneGOLGA8R.,2L0ThiscnvpartiallyoverlapstheGOLGA8Rgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
15	32445808	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=4;Span=9741;GeneNames=GOLGA8O;GeneIDs=728047;Genes=1;TranscriptNameClinicallyRelevant=NM_001277308.1;OverlappingExonsClinicallyRelevant=1-16;HGVSg=NC_000015.10:g.32445808_32455548dup;HGVScClinicallyRelevant=NM_001277308.1:c.1_1459dup;HGVSpClinicallyRelevant=NP_001264237.1:p.R487Nfs*27;ISCNCytobandNotation=dup(15)q13.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=32455548	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:128.516:1.38014:1.6194:0.000280943450974994:GOLGA8O::GOLGA8O:NM_001277308.1:Benign:2L0ThiscnvpartiallyoverlapstheGOLGA8Ogenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
15	72661453	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=1;Span=4948;GeneNames=GOLGA6B;GeneIDs=55889;Aliases=GOLGA;Genes=1;TranscriptNameClinicallyRelevant=NM_018652.5;OverlappingExonsClinicallyRelevant=9-18;HGVSg=NC_000015.10:g.72661453_72666400dup;HGVScClinicallyRelevant=NM_018652.5:c.652-6_2082dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(15)q24.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=72666400	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:144.052:1.63393:1.63626:0.000194262231309967:GOLGA6B::GOLGA6B:NM_018652.5:Benign:2L0ThiscnvpartiallyoverlapstheGOLGA6Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	14945570	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=4;Span=29413;GeneNames=NPIPA1,PDXDC1,PKD1P3-NPIPA1;GeneIDs=109951030,9284,23042;Genes=3;TranscriptNameClinicallyRelevant=NM_006985.4,NM_001285447.1,NR_146231.1;OverlappingExonsClinicallyRelevant=3-8,1,33-39;HGVSg=NC_000016.10:g.14945570_14974982dup;HGVScClinicallyRelevant=NM_006985.4:c.193-4_1053dup,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(16)p13.11;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.;RegionClinicallyRelevant=exon,.,.;Region=16:14886020-14969848,16:14887108-15026261,16:14954444-15001213,16:14954619-15037695,16:14957105-14983018;Span2=83829,139154,46770,83077,25914;OverlapType=Partial Overlap,Within Region,Partial Overlap,Partial Overlap,Partial Overlap;Name=gssvG14176,gssvG14160,gssvG14191,gssvG14171,gssvG14223;Frequency=0.001,0.0188,0.0025,0.0031,0.8083;Type2=Gain,Gain,Gain,Gain,Gain;Region2=16:14954912-14969860,16:14957313-15029375,16:14964502-14979101;Span3=14949,72063,14600;OverlapType2=Contains Region,Partial Overlap,Partial Overlap;Type3=Duplication,Duplication,Duplication;Frequency2=0.0099679,0.268458,0.000506842;DeletionFrequency=0,0,0;DuplicationFrequency=0.0099679,0.268458,0.000506842;END=14974982	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:103.572:1.94177:1.73764:5.17729911963431e-05:NPIPA1,PDXDC1,PKD1P3-NPIPA1::NPIPA1:NM_006985.4:Benign:2L0ThiscnvpartiallyoverlapstheNPIPA1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	15009660	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=1;Span=19381;GeneNames=MIR1972-1,PDXDC1;GeneIDs=23042,100302243;Aliases=LP8165;Genes=2;TranscriptNameClinicallyRelevant=NR_036054.1,NM_015027.4;OverlappingExonsClinicallyRelevant=All,8-15;HGVSg=NC_000016.10:g.15009660_15029040dup;HGVScClinicallyRelevant=.,NM_015027.4:c.649-21_1293+74dup;HGVSpClinicallyRelevant=.,NP_055842.2:p.D217_W431dup;ISCNCytobandNotation=dup(16)p13.11;SequenceOntologyClinicallyRelevant=.,inframe_insertion;RegionClinicallyRelevant=.,exon;Region=16:14954619-15037695,16:14986410-15022400;Span2=83077,35991;OverlapType=Within Region,Partial Overlap;Name=gssvG14171,gssvG14206;Frequency=0.0031,0.7971;Type2=Gain,Gain;Region2=16:14957313-15029375;Span3=72063;OverlapType2=Within Region;Type3=Duplication;Frequency2=0.268458;DeletionFrequency=0;DuplicationFrequency=0.268458;END=15029040	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:150.991:1.57393:1.33875:3.32684086776833e-05:MIR1972-1,PDXDC1::PDXDC1:NM_015027.4:VUS:2L0ThiscnvpartiallyoverlapsthePDXDC1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	28605818	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=11;Span=3087;GeneNames=SULT1A1;GeneIDs=6817;Aliases=HAST1/HAST2,P-PST,P-PST 1,PST,ST1A1,ST1A3,STP,STP1,TSPST1,ts-PST;Genes=1;TranscriptNameClinicallyRelevant=NM_001055.4;OverlappingExonsClinicallyRelevant=2-8;HGVSg=NC_000016.10:g.28605818_28608904dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p11.2;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=28608904	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:366.344:2.45883:1.47077:1.79821617074522e-08:SULT1A1::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	74410910	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=1;Span=9696;GeneNames=CLEC18B;GeneIDs=497190;Aliases=MRCL2;Genes=1;TranscriptNameClinicallyRelevant=NM_001385193.1;OverlappingExonsClinicallyRelevant=2-9;HGVSg=NC_000016.10:g.74410910_74420605dup;HGVScClinicallyRelevant=NM_001385193.1:c.125-13_1109dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)q23.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region=16:74393258-74431487;Span2=38230;OverlapType=Within Region;Name=gssvG15274;Frequency=1;Type2=Gain;Region2=16:74409284-74414922;Span3=5639;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.025;DeletionFrequency=0;DuplicationFrequency=0.025;END=74420605	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:197.158:1.38155:1.3714:0.000113535345803298:CLEC18B::CLEC18B:NM_001385193.1:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46693inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneCLEC18B.,2L0ThiscnvpartiallyoverlapstheCLEC18Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
17	16761416	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=8;Span=28024;GeneNames=CCDC144A,FAM106C,USP32P1;GeneIDs=9720,162632,100129396;Genes=3;TranscriptNameClinicallyRelevant=NM_001382000.1,NR_170993.1,NR_003190.2;OverlappingExonsClinicallyRelevant=13-17,All,1-2;HGVSg=NC_000017.11:g.16761416_16789439dup;HGVScClinicallyRelevant=NM_001382000.1:c.3373-9_4278dup,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(17)p11.2;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.;RegionClinicallyRelevant=exon,.,.;Region=17:16753287-16820986;Span2=67700;OverlapType=Within Region;Name=gssvG16012;Frequency=0.4635;Type2=Gain;END=16789439	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:204.926:2.01549:1.48716:1.00169740495843e-07:CCDC144A,FAM106C,USP32P1::CCDC144A:NM_001382000.1:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46702inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneCCDC144A.,2L0ThiscnvpartiallyoverlapstheCCDC144Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
17	46094551	.	N	<DEL>	.	.	Type=Loss;Targets=9;Samples2=5;Span=227858;GeneNames=ARL17B,KANSL1,KANSL1-AS1,LRRC37A;GeneIDs=284058,644246,100506084,9884;Aliases=CENP-36,KDVS,KIAA1267,MSL1v1,hMSL1v1;Genes=4;TranscriptNameClinicallyRelevant=NM_001103154.2,NM_001193466.2,NR_034172.1,NM_014834.4;OverlappingExonsClinicallyRelevant=4-5,1-3,All,1-6;HGVSg=NC_000017.11:g.46094551_46322408del;HGVScClinicallyRelevant=NM_001103154.2:c.260-22743_378del,NM_001193466.2:c.1_1431+9del,.,NM_014834.4:c.1_2978+15del;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=del(17)q21.31;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation,.,transcript_ablation;RegionClinicallyRelevant=exon,exon,.,exon;Region=17:46088437-46276519,17:46088904-46234597,17:46092761-47091135,17:46099606-46380808,17:46114400-46177128,17:46114400-46214953,17:46146542-46717206,17:46151528-46215377,17:46169584-46291969,17:46228609-46289299;Span2=188083,145694,998375,281203,62729,100554,570665,63850,122386,60691;OverlapType=Partial Overlap,Partial Overlap,Within Region,Partial Overlap,Contains Region,Contains Region,Partial Overlap,Contains Region,Contains Region,Contains Region;Name=gssvL49597,gssvL49601,gssvL49591,gssvL49596,gssvL49609,gssvL49606,gssvL49593,gssvL49607,gssvL49603,gssvL49608;Frequency=0.0039,0.0151,0.0221,0.0153,0.0013,0.0038,0.1703,0.0004,0.0043,0.001;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;END=46322408	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:50.6494:-1.32625:0.462394:0.000202840170757135:ARL17B,KANSL1,KANSL1-AS1,LRRC37A:KANSL1:KANSL1:NM_001193466.2:VUS:2C-10.9Thecnvoverlapsthe5'endoftheKANSL1geneandthecodingsequenceisinvolved,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
19	7051032	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=8;Span=7611;GeneNames=MBD3L2,MBD3L3;GeneIDs=125997,653657;Genes=2;TranscriptNameClinicallyRelevant=NM_144614.4,NM_001164425.4;OverlappingExonsClinicallyRelevant=2,All;HGVSg=NC_000019.10:g.7051032_7058642dup;HGVScClinicallyRelevant=NM_144614.4:c.46-9_627dup,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)p13.2;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;END=7058642	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:217.44:2.72352:1.90729:1.06995031095365e-05:MBD3L2,MBD3L3::MBD3L2:NM_144614.4:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46505inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneMBD3L2.,2L0ThiscnvpartiallyoverlapstheMBD3L2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
19	43355662	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=3;Span=448;GeneNames=CD177;GeneIDs=57126;Aliases=HNA-2a,HNA2A,NB1,NB1 GP,PRV-1,PRV1;Genes=1;TranscriptNameClinicallyRelevant=NM_020406.4;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000019.10:g.43355662_43356109dup;HGVScClinicallyRelevant=NM_020406.4:c.381_619+1dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.31;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=43356109	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:62.6292:2.80729:1.53838:0.000217200989897165:CD177::CD177:NM_020406.4:Benign:2L0ThiscnvpartiallyoverlapstheCD177genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
19	49958254	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=2836;GeneNames=SIGLEC11;GeneIDs=114132;Genes=1;TranscriptNameClinicallyRelevant=NM_052884.3;OverlappingExonsClinicallyRelevant=1-8;HGVSg=NC_000019.10:g.49958254_49961089dup;HGVScClinicallyRelevant=NM_052884.3:c.1_1651+29dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.33;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region2=19:49958707-49959668;Span3=962;OverlapType2=Contains Region;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=49961089	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:196.326:2.33146:1.28605:1.1230441131872e-06:SIGLEC11::SIGLEC11:NM_052884.3:VUS:2L0ThiscnvpartiallyoverlapstheSIGLEC11genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	49969657	.	N	<DEL>	.	.	Type=Loss;Targets=6;Samples2=1;Span=2494;GeneNames=SIGLEC16;GeneIDs=400709;Aliases=SIGLECP16,Siglec-P16;Genes=1;TranscriptNameClinicallyRelevant=NM_001348364.2;OverlappingExonsClinicallyRelevant=1-7;HGVSg=NC_000019.10:g.49969657_49972150del;HGVScClinicallyRelevant=NM_001348364.2:c.1_1273+49del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(19)q13.33;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=49972150	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:83.1625:-2.34035:0.594522:7.99009237301725e-08:SIGLEC16::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
19	52888130	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=2147;GeneNames=ZNF320;GeneIDs=162967;Aliases=ZFPL;Genes=1;TranscriptNameClinicallyRelevant=NM_001351774.2;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000019.10:g.52888130_52890276dup;HGVScClinicallyRelevant=NM_001351774.2:c.1_139dup;HGVSpClinicallyRelevant=NP_001338703.1:p.L47Hfs*42;ISCNCytobandNotation=dup(19)q13.41;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=52890276	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:201.517:3.02635:1.47623:6.58904954074132e-05:ZNF320::ZNF320:NM_001351774.2:VUS:2L0ThiscnvpartiallyoverlapstheZNF320genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
X	49533882	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=27;Span=57435;GeneNames=GAGE2A,GAGE12C,GAGE12D,GAGE12E,GAGE12F,GAGE12G,GAGE12H;GeneIDs=729422,100132399,729431,100008586,645073,729442,729447;Aliases=GAGE-12B;Genes=7;TranscriptNameClinicallyRelevant=NM_001127212.4,NM_001098408.3,NM_001127199.3,NM_001098418.3,NM_001098405.3,NM_001098409.4,NM_001098410.3;OverlappingExonsClinicallyRelevant=1-3,3-5,All,All,All,All,All;HGVSg=NC_000023.11:g.49533882_49591316dup;HGVScClinicallyRelevant=NM_001127212.4:c.1_201dup,NM_001098408.3:c.86_354dup,.,.,.,.,.;HGVSpClinicallyRelevant=NP_001120684.1:p.M1_Q67dup,.,.,.,.,.,.;ISCNCytobandNotation=dup(X)p11.23;SequenceOntologyClinicallyRelevant=inframe_insertion,3_prime_UTR_variant,.,.,.,.,.;RegionClinicallyRelevant=exon,UTR3,.,.,.,.,.;Region=X:49528798-49617313;Span2=88516;OverlapType=Within Region;Name=gssvG40918;Frequency=0.3171;Type2=Gain;END=49591316	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:245.76:1.75005:2.41413:6.4712426060042e-05:GAGE2A,GAGE12C,GAGE12D,GAGE12E,GAGE12F,GAGE12G,GAGE12H::GAGE12D:NM_001127199.3:Benign:2B0WhiletheCNVoverlapstheGAGE12DgeneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-46290inClinGenDosageSensitivity.,2G0TheCNVisoverlapsthetriplobenignregionISCA-46541inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps7proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
X	154150646	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=3;Span=316;GeneNames=OPN1LW;GeneIDs=5956;Aliases=CBBM,CBP,COD5,RCP,ROP;Genes=1;TranscriptNameClinicallyRelevant=NM_020061.6;OverlappingExonsClinicallyRelevant=2;HGVSg=NC_000023.11:g.154150646_154150961del;HGVScClinicallyRelevant=NM_020061.6:c.113-10_409+9del;HGVSpClinicallyRelevant=NP_064445.2:p.P39_G137del;ISCNCytobandNotation=del(X)q28;SequenceOntologyClinicallyRelevant=inframe_deletion;RegionClinicallyRelevant=exon;END=154150961	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-9.23309:0:4.96260171424421e-18:OPN1LW::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:0
